RPL3 and colonic neoplasm: It is known that the CBS promoter contains an Sp1 binding site, and Sp1 is essential in the control of CBS transcription [79], In colon cancer cells which devoid of p53, the chemotherapeutic drug 5-FU can induce ribosomal protein L3 (rpL3) as proapoptotic factor.